Completed
Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma
NCT02278315
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Mayo Clinic Jacksonville, Florida, United States
- Loyola University Medical Center Maywood, Illinois, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
- University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States